METASTATIC MALIGNANT MELANOMA - A CASE REPORT
Abstract
Melanoma is a malignant neoplasm of
melanocytes innate to the skin and other
sites. Melanoma accounts for 1 to 3 of all
malignancies. Melanoma is commonly
known to metastasis to lymph nodes, and
adjoining skin and subcutaneous tissue.
Metastatic deposition in liver, lung and
spine are rarely reported. We present here
a case report of malignant melanoma with
multiple metastases for its rare clinical
presentation.
Full Text:
PDFReferences
A. Jemal, R. Siegel, E. Ward, Y. Hao,
J. Xu, and M. J. Thun, “Cancer statistics,
,” CA Cancer Journal for Clinicians,
vol. 59, no. 4, pp. 225–249,
Goldgeier MH, Klein LE, Klein-
Angerer S, Moellmann G, Nordlund JJ.
The distribution of melanocytes in the
leptomeninges of the human brain. J
Invest Dermatol. 1984;82:235–238.
Dupin E, Le Douarin NM. Development
ofmelanocyte precursors from the
v e r t e b r a t e n e u r a l
crest. Oncogene. 2003;22:3016–23.
Balch CM, Buzaid AC, Soong SJ, Atkins
MB, Cascinelli N, Coit DG, et al.
Final version of the American Joint
Committee on Cancer staging system
for cutaneous melanoma. J Clin Oncol.
Aug 15 2001;19(16):3635-48.
A. Tejera-Vaquerizo, M. V. Barrera-
Vigo, I. Fernández-Canedo et al.,
“Longitudinal study of different metastatic
patterns in the progression of cutaneous
melanoma,” Actas Dermo-
Sifiliograficas, vol. 98, no. 8, pp. 531–
, 2007
S.-J. Soong, R. A. Harrison, W. H.
McCarthy, M. M. Urist, and C. M. Balch,
“Factors affecting survival following local,
regional, or distant recurrence from localized
melanoma,” Journal of Surgical Oncology,
vol. 67, no. 4, pp. 228–233, 1998
M. B. Atkins, A. Hauschild, R. L. Wahl,
and C. M. Balch, “Diagnosis of Stage IV
melanoma,” in Cutaneous Melanoma, C.
M. Balch, A. N. Houghton, A. J. Sober, S.
J. Soong, M. B. Atkins, and J. F. Thompson,
Eds., pp. 573–602, Quality Medical
Publishing, St. Louis, Mo, USA, 5th edition,
J. E. Gershenwald, C. M. Balch, S. J.
Soong, and J. F. Thompson, “Prognostic
factors and natural history of melanoma,”
in Cutaneous Melanoma, C. M. Balch, A.
N. Houghton, A. J. Sober, S.
J. Soong, M. B. Atkins, and J. F.
Thompson, Eds., pp. 35–64, Quality
Medical Publishing, St. Louis, Mo, USA,
th edition, 2009
C. M. Balch, S. J. Soong, J. E. Gershenwald
et al., “Prognostic factors analysis
of 17,600 melanoma patients: validation
of the American Joint Committee on
Cancer melanoma staging system,” Journal
of Clinical Oncology, vol. 19, no. 16,
pp. 3622–3634, 2001
J. E. Gersenhenwald, D. L. Morton, J. F.
Thompson, et al., “Staging and prognostic
factors for stage IV melanoma: initial results
of an American Joint Committee on
Cancer (AJCC) international evidencebased
assessment of 4895 melanoma patients.
Forty-fourth Annual Meeting of the
American Society of Clinical Oncology,
Chicago, IL, May 2008,” Journal of Clinical
Oncology, vol. 26, supplement, abstract
, 2008
C. M. Balch, S. Soong, and T. M. Murad,
“A multifactorial analysis of melanoma.
IV. Prognostic factors in 200 melanoma
patients with distant metastases
(stage III),” Journal of Clinical Oncology,
vol. 1, no. 2, pp. 126–134, 1983
A. Barth, L. A. Wanek, and D. L. Morton,
“Prognostic factors in 1,521 melanoma
patients with distant metastases,” Journal
of the American College of Surgeons, vol.
, no. 3, pp. 193–201, 1995
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An Initiative of The Tamil Nadu Dr M.G.R. Medical University